Executive Committee

Meet our Executive Committee members below

The purpose of BOPA, which is a registered charity, is to promote excellence in the pharmaceutical care of patients with cancer through education, communication, research and innovation by an alliance of hospital, community and academic pharmacists, pharmacy technicians, those in the pharmaceutical industry and other healthcare professionals.

The BOPA executive committee is a group of volunteers who have been elected by the membership to deliver BOPA’s aims and objectives. The committee consists of 9 to 14 permanent members who serve a term of 3 years. Committee roles include Chair, Vice Chair, Treasurer, Secretary, New to Oncology Representative, Independent Sector representative and Pharmacy Technician Representative.

Emma Foreman

Chair

Emma Foreman

Emma is a Consultant Pharmacist at the Royal Marsden Hospital in London. She has an MSc in Clinical Oncology and is an Independent Prescriber. Emma is currently Joint Chair of BOPA as well as Chair of the ISOPP Biosimilars Taskforce and a reviewer for the Journal of Oncology Pharmacy Practice. She was awarded the BOPA/PRUK research award in 2018 for a study investigating drug interactions between enzalutamide and DOACs. Emma is a visiting lecturer at the University of Brighton and enjoys teaching on the BOPA Intro to Oncology Study Day . Her special interests include renal cancer, drug interactions, non-medical prescribing (and canoeing!).

Seonaid McLachlan

Chair

Seonaid McLachlan

Seonaid McLachlan is Principal Pharmacist for Cancer Services in NHS Ayrshire & Arran. Seonaid is currently Joint Chair of BOPA and she is also a member of the Scottish Oncology Pharmacy Practice Group (SOPPG) and is the formal link between BOPA and SOPPG. As well as working for many years as a cancer care pharmacist, Seonaid has previously worked with the Scottish Medicines Consortium undertaking horizon scanning for cancer medicines in Scotland and was the pharmacy lead on the recent West of Scotland Strategic Review of Cancer Services. Her interests include service planning and redesign, particularly focusing on role development for pharmacists and technicians working in cancer services.

Netty Cracknell

Secretary

Netty Cracknell

Netty is an experienced oncology pharmacist and has worked for over 15 years in this sector. She has a vast range of experience including lead oncology and haemato-oncology pharmacist within an NHS Trust, a lead role within an NHS cancer network, and project management roles for the implementation of SACT electronic prescribing both in the NHS and the independent sector. During these 15 years Netty has been an active member of BOPA and her current role within the executive committee is the BOPA secretary and Co-Chair of the Digital Subcommittee.

Netty also chairs the Independent Sector Oncology Pharmacy Group and is a member of the Independent Sector Cancer Network and UK Chemotherapy Forum where she represents BOPA. She is passionate about improving cancer care within the independent sector and improving safety for patients and staff with the use of digital media.

Rob Duncombe

Treasurer

Rob Duncombe

Professor Rob Duncombe. Director of Pharmacy at The Christie NHS Foundation Trust in Manchester. The Christie is one of the largest cancer centres in Europe treating patients from across the UK. The hospital recently opened the first NHS proton beam centres in the UK, and is one of the first hospitals to offer CAR T therapy to patients. Professor Duncombe has a particular interest in medicines optimisation in cancer drugs, identifying ways to achieve the best value from the use of these medicines. In recent years Prof Duncombe has been at the forefront of delivering dose-banded chemotherapy in the UK and the introduction of biosimilar medicines in cancer.